What are semaglutide dissolving tablets for weight loss? The Found guide
Learn about oral semaglutide options at Found, including Rybelsus pills and the new compounded oral semaglutide dissolving tablets.
Learn about oral semaglutide options at Found, including Rybelsus pills and the new compounded oral semaglutide dissolving tablets.
If you’ve been wanting to try a GLP-1 weight loss medication but dread injecting yourself with needles, oral versions of semaglutide—including the new compounded oral semaglutide dissolving tablets available from Found—might be an option.
What are they, and how do they compare to other forms of semaglutide? We’ll explain.
Compounded medications are made in a licensed pharmacy. These medications are designed to meet an individual’s specific health needs. Because there is currently no FDA-approved semaglutide oral dissolving tablet (ODT) on the market, licensed pharmacies can make an ODT version of the semaglutide to meet the unique needs of individual consumers.
Although compounded medications do not have FDA approval, the U.S. Food and Drug Administration permits them in certain circumstances, and licensed compounding pharmacies must meet strict quality standards. Compounded medications can be more affordable than brand-name drugs, and they may also be designed to meet the individual needs of those who have allergies to available formulations or other concerns about the brand-name version of a drug.
At Found, compounded semaglutide oral dissolving tablets cost $189 for a 28-day supply. That doesn’t include the cost of clinical visits, labs, or a Found subscription—which provides access to a health coach as well as lifestyle change education and support from a community of fellow Found members within the Found app. (Read more about getting a compounded semaglutide prescription through Found.)
Found only uses U.S.-based licensed pharmacies to supply its compounded medications. Epiq Scripts of Richardson, Texas, is Found’s vendor for compounded oral semaglutide dissolving tablets. Found is not affiliated with Novo Nordisk A/S, the owner of the registered trademarks Rybelsus, Ozempic and Wegovy.
Semaglutide is a glucagon-like peptide 1 receptor agonist, or GLP-1 receptor agonist. That means it mimics GLP-1, one of the body’s naturally occurring hormones. In clinical trials, semaglutide has helped people (some with and some without type 2 diabetes) regulate blood sugar, feel fuller, and lose weight. More recent studies found it also can lower the risk of heart attack, stroke, and other adverse events in those with preexisting cardiovascular disease.
Researchers believe semaglutide works in several ways:
It’s important to note that most published clinical trials about the effects of oral semaglutide thus far have involved pills swallowed whole with water—not ODTs, which dissolve rapidly under the tongue or between the gum and cheek and have different dosages.
In such studies, oral semaglutide pills appear to be as effective as semaglutide injections as a treatment for obesity. In one large placebo-controlled trial, people who took a daily dose of oral semaglutide (25 mg) lost an average of 13.6% of their baseline body weight after 64 weeks. This loss is comparable to the weight lost by people who took the highest dose of injected semaglutide (2.4 mg a week) in similar clinical trials.
For diabetes care, one study found that once-daily oral semaglutide pills (not ODTs) may be less effective for lowering glucose levels in people with later onset of type 2 diabetes as compared to those with a more recent diagnosis of diabetes. However, other studies found that oral semaglutide, sometimes in combination with metformin, can be as effective as subcutaneous semaglutide for glycemic control. And recent results from a clinical trial indicated the effect of oral semaglutide may be similar to that of subcutaneous semaglutide injections in lowering blood pressure and reducing the risk of cardiovascular disease or cardiovascular events.
Though compounded medications are FDA-permitted from licensed pharmacies and reviewed for adverse events after they are sold, compounded drugs, including oral semaglutide dissolving tablets, are not FDA-approved and have not undergone pre-market clinical studies for safety or efficacy. So, we don’t know how oral semaglutide dissolving tablets will compare.
Since oral forms of semaglutide aren’t labeled or FDA-approved as obesity treatments, researchers are still studying what dose is most effective for weight loss.
Approved at doses of up to 14 mg daily as a treatment for type 2 diabetes, Rybelsus is available in 3 mg and 7 mg tablets. However, in clinical trials, doses of 50 mg per day were most effective for weight loss.
Adele Feng, PharmD, director of clinical operations at Found, notes that oral dissolving tablets typically require less of an active ingredient than pills that are swallowed. That’s because the oral dissolving medicine passes directly into the bloodstream through the delicate tissues under the tongue or in the gums and cheek, rather than moving through and breaking down in the digestive system.
Epiq Scripts, the vendor of compounded oral semaglutide dissolving tablets available from Found, recommends starting most patients at 1 mg dose per day for the first month and progressing to 2 mg a day thereafter or, for patients who are making a switch from injectable semaglutide, starting most at a 4 mg dose per day for the first month and progressing to 6 mg a day.
At Found, while decisions about whether a patient is qualified for medication and what dosage to prescribe ultimately rest with the provider, Found clinicians work closely with each patient to determine the best formulation and most effective dose for their needs.
All GLP-1 medications have known potential side effects. The most common are nausea, vomiting, diarrhea, and constipation. More serious but less common side effects include pancreatitis, gallbladder disease, gastroparesis (stomach paralysis), and worsening of diabetic eye disease, as well as pulmonary aspiration while under general anesthesia or deep sedation. Those with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias should not use them.
Side effects and risks differ by brand and formulation. And compounded medications, which lack pre-market clinical study and FDA approval, may include different non-active ingredients and pose additional risks or cause additional side effects.
Find details about side effects and risks for specific medications by name on our dedicated medication page.
Here are some key differences among injectable semaglutide, oral semaglutide, and compounded oral semaglutide dissolvable tablets:
Frequency:
With or without food/water:
Method of administration:
Dose escalation:
Lifestyle interventions:
While that’s a question best explored with your health care provider, oral semaglutide may be an alternative for those seeking the benefits of semaglutide without injections. Whether you choose the FDA-approved Rybelsus or compounded oral dissolving tablets, your Found provider can help you find the right combination of medication and lifestyle changes to achieve your weight management goals.
About Found
Found is among the largest medically-supported telehealth weight care clinics in the country, having served more than 250,000 members to date. To start your journey with Found, take our quiz.
While GLP-1s are effective for weight loss, they are not clinically appropriate for everyone. Eligibility for a GLP-1 is based on a provider’s evaluation of your medical history, MetabolicPrint, and lab work. If a GLP-1 is not appropriate for you, a provider will work with you to determine an effective medication for your health profile. This content does not provide medical advice and does not substitute for a consultation with a doctor or health care provider.
Get the best of Found right in your inbox
Get started with Found
Ready to lose weight and live your healthiest life?